Scientific article
English

Chrono-pharmacological Targeting of the CCL2-CCR2 Axis Ameliorates Atherosclerosis

Published in

Cell Metabolism, vol. 28, no. 1, p. 175-182.e5

Publication date

2018

Abstract

Onset of cardiovascular complications as a consequence of atherosclerosis exhibits a circadian incidence with a peak in the morning hours. Although development of atherosclerosis extends for long periods of time through arterial leukocyte recruitment, we hypothesized that discrete diurnal invasion of the arterial wall could sustain atherogenic growth. Here, we show that myeloid cell recruitment to atherosclerotic lesions oscillates with a peak during the transition from the activity to the resting phase. This diurnal phenotype is regulated by rhythmic release of myeloid cell-derived CCL2, and blockade of its signaling abolished oscillatory leukocyte adhesion. In contrast, we show that myeloid cell adhesion to microvascular beds peaks during the early activity phase. Consequently, timed pharmacological CCR2 neutralization during the activity phase caused inhibition of atherosclerosis without disturbing microvascular recruitment. These findings demonstrate that chronic inflammation of large vessels feeds on rhythmic myeloid cell recruitment, and lay the foundation for chrono-pharmacology-based therapy.

UNIGE affiliation entities

Not a UNIGE publication

Citation (ISO format)

WINTER, Carla et al. Chrono-pharmacological Targeting of the CCL2-CCR2 Axis Ameliorates Atherosclerosis. In: Cell Metabolism, 2018, vol. 28, n° 1, p. 175–182.e5. doi: 10.1016/j.cmet.2018.05.002

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

1550-4131
611views
1downloads

Technical informations

Creation

29/11/2018 10:56:00

First validation

29/11/2018 10:56:00

Update

15/03/2023 15:39:10

Status update

15/03/2023 15:39:08

Last indexation

31/10/2024 12:34:09
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated